Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma. - van Meerten T; Kuruvilla J; Song KW; Thieblemont C; Minnema MC; Forcade E; De Guibert S; Kersten MJ; Mutsaers PG; Wermke M; Zheng Y; Xue A; et al. (American journal of cancer research, 2024)